Related Experiment Video
Updated: Jul 3, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Hepatitis C virus in elderly patients with chronic liver diseases
M Russello1, R Benigno, M Zammataro
1Division of Internal Medicine, Catania University, Ospedale Garibaldi, Piazza S. Maria di Gesir, I-95100 Catania, Italy.
Insights
Hepatitis C virus (HCV) is the most common cause of chronic liver disease (CLD) in elderly patients. Co-infection with alcoholism increases liver damage severity, necessitating long-term monitoring for HCV-induced CLD.
Area of Science:
- Hepatology
- Virology
- Geriatric Medicine
Background:
- Chronic liver diseases (CLD) pose a significant health burden, particularly in aging populations.
- Understanding the etiological agents and their prevalence in elderly patients is crucial for effective management.
- Hepatitis C virus (HCV) is a major cause of chronic liver disease globally.
Purpose of the Study:
- To evaluate the prevalence of hepatitis C virus (HCV) in elderly patients with chronic liver diseases (CLD).
- To compare the prevalence and characteristics of HCV with hepatitis B and D virus (HBV and HDV) infections in this demographic.
- To assess the impact of co-existing alcoholism on the severity and progression of HCV-induced liver disease.
Main Methods:
- A cohort of 141 consecutive patients over 50 years of age with CLD was recruited between January 1993 and July 1994.
- Prevalence of HCV, HBV, and HDV infections was determined using serological tests.
- Patient demographics, including age and history of alcoholism, were recorded and analyzed.
Main Results:
- HCV was the predominant cause of CLD, with an overall prevalence of 50.3% (71/141).
- The prevalence of HCV increased to 70.1% when considered with alcoholism.
- Hepatitis B and D virus (HBV/HDV) infections were less common (17%, 24/141).
- HCV patients were significantly older than HBV/HDV patients (p < 0.001), suggesting slower HCV evolution.
- HCV associated with alcoholism showed increased liver damage severity, indicated by a younger mean age in this subgroup.
- HCV-induced liver cirrhosis progressed to carcinoma in 9.8% (5/51) of cases, linked to disease duration.
Conclusions:
- HCV is the most frequent cause of CLD in elderly patients in the studied region.
- Elderly patients with HCV-induced CLD require long-term monitoring due to the risk of progression to liver carcinoma.
- Alcoholism exacerbates liver damage in HCV patients, highlighting the need for comprehensive management strategies.
Abstract:
Between January 1993 and July 1994, 141 consecutive patients were recruited, all above 50 years of age, affected by chronic liver diseases (CLD), in order to evaluate the prevalence of hepatitis C virus (HCV). The overall prevalence of HCV alone was 50.3% (71 out of 141 patients) which increased to 70.1% when considered together with the alcoholism (28 out of 141 patients). Contrastingly, the prevalence of hepatitis B and D virus (HBV and HDV) was low (17%, 24 patients). Mean age of HCV patients was significantly higher than the mean age of HBV/HDV patients (p < 0.001). There was a significant difference (p < 0.05) between the mean age of the group of patients with only HCV and those where the disease was associated with alcoholism. Our data indicate that HCV is by far the most frequent cause of CLD in elderly patients in our geographical area. The mean age of HCV-induced CLD patients was significantly higher than the mean age of HBV/HDV patients, due to the slower evolution of HCV. The severity of liver damage increases if HCV is associated with alcoholism, as shown by the lower age of these subjects. HCV induced liver cirrhosis often develops into carcinoma (in 5 out of 51 patients in our series, 9.8%) and may be a result of the longer duration of the disease. This seems to be the only factor aggravating the otherwise slow evolution of HCV. Our data suggest the necessity of long term monitoring of elderly patients with HCV-induced CLD.
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology

